In late 2019, researchers at the MIT Laboratory for Financial Engineering (LFE) and the MIT Computer Scie...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and COVAX (COVID-19 Vaccines Global Access) partners...
The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the wa...
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...
Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced the appointment of...
Aptamer Group, the UK-based developer of Optimer therapeutics and diagnostics, has secured a contract with a top-five gl...
The new Partnership for Vivax Elimination (PAVE) launched on July 14, will support countries in the elimination of P. vi...
Access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and ...
DrAnsay.com, the market leader for online doctor attests, is offering online test certificates for self-applied rapid an...
South Korea-based International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUS...
More than 50 countries around the world from Latin America, Africa, and Asia have shown interest in India's vaccina...
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. ...
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...
Novasep, a leading supplier of services and technologies for the life sciences industry, announced a €6.1 million (...
The World Health Organization (WHO) and its COVAX partners are working with a South African consortium compris...
Agilent Technologies Inc. has announced the launch of three InfinityLab Bio LC systems specifically devel...
Multinational consultancy firm based in Dublin, Linesight, announced that the collaboration it is leading with major glo...
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...
